AstraZeneca (AZN)
(Delayed Data from NSDQ)
$78.36 USD
+0.23 (0.29%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $78.35 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Brokerage Reports
0 items in cart
AstraZeneca PLC [AZN]
Reports for Purchase
Showing records 101 - 120 ( 259 total )
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 15
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 13
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Biotechnology: Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended January 17 2020
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AstraZeneca PLC
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department